University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome

dc.contributor.authorToft-Petersen, Marie
dc.contributor.authorNederby, Line
dc.contributor.authorKjeldsen, Eigil
dc.contributor.authorKerndrup, Gitte B
dc.contributor.authorBrown, Gordon D
dc.contributor.authorHokland, Peter
dc.contributor.authorStidsholt Roug, Anne
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.MRC Centre for Medical Mycologyen
dc.date.accessioned2016-11-24T12:28:20Z
dc.date.available2016-11-24T12:28:20Z
dc.date.issued2016-11
dc.descriptionAcknowledgements The authors would like to thank Petter S. Woll, MSc, PhD, Karolinska Institutet, Stockholm, Sweden, for the kind and generous supervision of the LTC-IC experiments. We thank the FACS Core Facility at Aarhus University for access to the cell sorter and Pia S. Kristensen, Department of Haematology, Aarhus University Hospital for her excellent technical assistance conducting the FISH experiments. The Karen Elise Jensen Foundation, The Meyer Foundation, The Wellcome Trust and the Danish Cancer Society supported the study.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent392432
dc.identifier71167812
dc.identifier6dab8033-63e4-48f4-973c-2fc6e566d796
dc.identifier27612176
dc.identifier84987624325
dc.identifier.citationToft-Petersen, M, Nederby, L, Kjeldsen, E, Kerndrup, G B, Brown, G D, Hokland, P & Stidsholt Roug, A 2016, 'Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome', British Journal of Haematology, vol. 175, no. 3, pp. 393-401. https://doi.org/10.1111/bjh.14270en
dc.identifier.doi10.1111/bjh.14270
dc.identifier.iss3en
dc.identifier.issn0007-1048
dc.identifier.urihttp://hdl.handle.net/2164/7739
dc.identifier.vol175en
dc.language.isoeng
dc.relation.ispartofBritish Journal of Haematologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectcancer stem cellsen
dc.subjectmyelodysplastic syndromeen
dc.subjecthMICLen
dc.subjectCD371en
dc.subjectLTC-ICen
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subject.lccRen
dc.titleUnravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndromeen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Toft_Petersen_et_al_2016_British_Journal_of_Haematology.pdf
Size:
383.23 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: